Abstract
Zika virus (ZIKV) is a member of the Flavivirus family. ZIKV infection
ranges from asymptomatic to a mild disease in adults. However, in 2015, ZIKV
infection became a public health emergency in the Americas associated with
neurological alterations such as Guillain-Barré syndrome (GBS) in adults and
congenital zika syndrome (CZS). By blocking type I IFN interferon signaling
pathways, ZIKV evades the immune system and infects cells expressing the T cell
immunoglobulin mucin domain-1 (TIM-1) and TAM (Tyro3, AXL, and Mer)
receptors, such as neural progenitor cells. Moreover, ZIKV seems to orchestrate a
process of astrocytic hypoxia that leads to the production of reactive oxygen species
(ROS), mitochondrial DNA (mtDNA) fragmentation, and apoptosis. In recent decades,
the active participation of mitochondria in the immuno-inflammatory response has
been reported in several pathologies. In this context, mtDNA seems to have an essential
role in triggering the innate immune response by activating inflammasomes, activating
the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING)
pathway, and also activating toll-like receptors that lead to IFN production and viral
clearance. Here, we present an overview of some mechanisms of inflammatory
response present in ZIKV infection, which contributes to mitochondrial dysfunction,
mtDNA release, and tissue damage.
Keywords: Inflammation, Mitochondrial DNA, Neuroinflammation, Zika virus.